Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Post-Operative Pain Following Total Knee Arthroplasty
Interventions
DEVICE

Pulsed Electromagnetic Field Device (Provant)

The PEMF device delivers non-thermal, non-ionizing pulsed electromagnetic energy to the target tissue, using 27.12 megahertz pulses lasting 42 microseconds and delivered 1000 times per second. The system generates an electromagnetic field that is continuously monitored and regulated to ensure consistent dosing. The therapeutic electromagnetic field is delivered by means of an applicator pad that is placed against the treatment site. The active and sham devices will be identical in appearance and all other physical characteristics in order to maintain the masking of the treatment.

DEVICE

Sham Pulsed Electromagnetic Field Device

The Sham device will be identical in appearance, physical characteristics and operation to the Active device.

Trial Locations (14)

10022

New York

29303

Spartanburg

80124

Lone Tree

84790

St. George

85018

Phoenix

85023

Phoenix

89128

Las Vegas

92020

El Cajon

99218

Spokane

Unknown

Birmingham

Bradenton

Fort Lauderdale

Raleigh

Danville

All Listed Sponsors
lead

Regenesis Biomedical, Inc.

INDUSTRY

NCT02211534 - Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter